HCA Healthcare, Inc. reports results for the quarter ended September 30 - Earnings Summary

What happened

HCA Healthcare reported quarterly adjusted earnings of $7.27 per share, above the $6.66 average expected by twenty three analysts. Revenue rose 3.6% to $19.85 billion, and quarterly net income was $1.58 billion.

Confirmed

Global impact / market context

Earnings beating expectations suggest HCA kept more profit per sale than analysts assumed, while revenue growth shows demand held up. That combination can support the share price because investors pay for future profits, and a beat reduces doubt about near term results.

Analyst inference

Analysts had cut earnings estimates by about 1.4% over three months, with five negative revisions in the last 30 days, so expectations were lower going into the report. The average rating is buy, and the $478 median price target sits 2.7% above the $465.26 last close.

Analyst inference

What to watch

1. Five analysts negatively revised earnings estimates in the last 30 days, and the mean estimate fell about 1.4% over three months, so watch whether downgrades continue after this beat. Confirmed
2. Watch whether the company's spending plans and cost trends are disclosed, since higher costs would reduce profit per sale and could offset revenue growth in future quarters. Proposed
3. Watch the gap between the $465.26 last close and the $478 median target, because the small upside suggests limited expected gain unless profits keep beating forecasts. Analyst inference

Evidence

• Original source link unavailable